Fujifilm Holdings
- All
- News
-
Fujifilm To Partner With Dr Reddy's To Sell Avigan As COVID-19 Treatment
Japan's Fujifilm Holdings Corp announced a deal with India's Dr Reddy's Laboratories and Dubai-based Global Response Aid (GRA) to sell its anti-flu drug Avigan for COVID-19 treatment globally excluding Japan, China and Russia.
-
Glenmark Gets Approval For Favipiravir As COVID-19 Treatment
Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014.
-
Xerox Ends 57-Year Venture With $2.3 Billion Sale to Fujifilm
Xerox Holdings agreed to sell 25 percent of Fuji Xerox to its Japanese partner, jettisoning its slice of the five-decade old venture after a merger attempt fell through.
-
Ebola Drug Trial in Guinea 'Encouraging': Researchers
An Ebola candidate treatment yielded "encouraging" results in an early-stage trial with 80 patients in Guinea, the French government and medical research agency Inserm said today.
-
Nikkei Rises to Two-Week High on Weak Yen
Japanese shares rose to a two-week high on Friday as the weaker yen lifted exporters, while renewed fears about the spread of the Ebola virus in the United States bolstered Ebola-related stocks such as Fujifilm Holdings Corp.
-
Fujifilm To Partner With Dr Reddy's To Sell Avigan As COVID-19 Treatment
Japan's Fujifilm Holdings Corp announced a deal with India's Dr Reddy's Laboratories and Dubai-based Global Response Aid (GRA) to sell its anti-flu drug Avigan for COVID-19 treatment globally excluding Japan, China and Russia.
-
Glenmark Gets Approval For Favipiravir As COVID-19 Treatment
Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014.
-
Xerox Ends 57-Year Venture With $2.3 Billion Sale to Fujifilm
Xerox Holdings agreed to sell 25 percent of Fuji Xerox to its Japanese partner, jettisoning its slice of the five-decade old venture after a merger attempt fell through.
-
Ebola Drug Trial in Guinea 'Encouraging': Researchers
An Ebola candidate treatment yielded "encouraging" results in an early-stage trial with 80 patients in Guinea, the French government and medical research agency Inserm said today.
-
Nikkei Rises to Two-Week High on Weak Yen
Japanese shares rose to a two-week high on Friday as the weaker yen lifted exporters, while renewed fears about the spread of the Ebola virus in the United States bolstered Ebola-related stocks such as Fujifilm Holdings Corp.
